Malnutrition among pregnant women increases in 12 countries at risk

Published Date: 08 Mar 2023

Malnutrition among pregnant and breastfeeding women has increased by 25% in the past two years in 12 countries affected by rising food prices caused by the war in Ukraine, according to United Nations news.

Read Full News

Latest News

Some Women Suffer Posttraumatic Stress After Vaginal Birth

About 1 in 20 women experience persistent or emerging symptoms of posttraumatic stress at 2 months after vaginal delivery, a study finds.

Adverse Childhood Experiences Tied to Higher PMOS Prevalence

Women who experience more difficult or harmful situations in their childhood have a higher prevalence of polyendocrine metabolic ovarian syndrome later in life.

Who Opts for Home Cervical Cancer Screening?

Home-based human papillomavirus screening for cervical cancer shows modest uptake in a diverse community setting.

Palbociclib Gains HER2+ Breast Cancer Maintenance Indication

Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.

Mirvetuximab Fails to Boost Survival in Platinum-Eligible OC

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.

Combined Oral Contraceptives Linked to Emotional Eating

Researchers find higher emotional eating scores during active pill use, though experts say the clinical significance remains unclear.

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Latest News

About 1 in 20 women experience persistent or emerging symptoms of posttraumatic stress at 2 months after vaginal delivery, a study finds.

Women who experience more difficult or harmful situations in their childhood have a higher prevalence of polyendocrine metabolic ovarian syndrome later in life.

Home-based human papillomavirus screening for cervical cancer shows modest uptake in a diverse community setting.

Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
HTTP error: 503

Researchers find higher emotional eating scores during active pill use, though experts say the clinical significance remains unclear.

News All Time

US FDA Extends Review Of AstraZeneca’s Experimental Breast Cancer Pill

AstraZeneca said on Wednesday the U.S. Food and Drug Administration has extended ⁠the decision deadline for the drugmaker's experimental breast cancer pill camizestrant to...
HTTP error: 503

Some Midwives Break the Law To Assist With Home Births

Midwives are helping more Georgia families with home births even though the practice is illegal, as demand rises and lawmakers clash over whether to legalize and regulate it.
HTTP error: 503HTTP error: 503HTTP error: 503

Treatment of Vulvodynia Differs by Race and Ethnicity

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways patients may describe pain and symptoms.
HTTP error: 503

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours
HTTP error: 503HTTP error: 503

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer
HTTP error: 503

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game
HTTP error: 503

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot